Zacks Investment Research | TalkMarkets | Page 7
Zacks Investment Research
Contributor's Links: Zacks Investment Research
Zacks Investment Research is one of the most highly regarded firms in the investment industry. The guiding principle behind our work is that there must be a good reason for brokerage firms to spend billions of dollars a year on stock research. Obviously, these investment experts know something ...more

Articles

Latest Posts
97 to 112 of 10116 Posts
<<< 1 ... 5 6 7 8 9 ... 633 >>>
Bear Of The Day: FMC
FMC stock has struggled in recent years, with its stock trading unchanged since 2019. Furthermore, its near-term prospects are not ideal, as analysts have lowered earnings estimates, and price action sets up another move lower.
3 Stocks To Buy For Decreased Volatility
Beta measures a stock's volatility in comparison to a relevant benchmark. The market, such as the S&P 500 Index, has a beta of 1.0.
Battle Of The Super AI Chips: Time To Buy Nvidia Or AMD's Stock?
The impeccable rally in Nvidia and AMD’s stock has started to wear thin over the last few weeks but of course, corrections can be healthy.
Time To Buy These Top-Rated Basic Materials Stocks Amid An Uptick In Inflationary Data
Markets have remained resilient despite February’s CPI and PPI data coming in hotter than anticipated but it may be time to consider buying several highly ranked basic materials stocks and here are a few to consider.
3 Metal Fabrication Stocks To Watch In A Promising Industry
The metal fabrication industry is poised to gain from demand in the end-use sectors, such as manufacturing, aerospace, and automotive. Here is a look at some players in this industry that may benefit from an improving economic environment.
3 Hot Auto Stocks To Buy In March
While Tesla’s stock has largely lagged the broader market, a few domestic automakers have outperformed thanks to their steady growth and attractive valuations.
3 Financial Mutual Funds To Buy As Inflation Stays Elevated
Here are three financial mutual funds that are expected to give a positive return amid the rise in inflation.
Bear Of The Day: AMN Healthcare Services
Labor shortages and staff burnout among nurses are reasons to be wary of AMN Healthcare Services (AMN)  stock despite the company’s favorable long-term prospects.
Tech Sector Resumes Growth Mode
As was the case in the preceding two quarters, the Tech sector remains a key growth driver in 2024 Q1. Had it not been for the robust Tech sector earnings growth, total earnings for the rest of the index would be modestly in negative territory.
Mastercard, Nexi To Revolutionize Payment Landscape In Europe
Mastercard Incorporated and Nexi, two giants in the payments industry, are joining forces to revolutionize payment landscape in Europe.
3 Large-Cap Value Mutual Funds To Strengthen Your Portfolio
Since the broader market trend is still uncertain, investors should look for stocks that tend to trade at a price lower than their fundamentals.
3 Companies Enjoying Robust Sales Growth
Consistent sales growth is key, as it’s the foundation of generating profits. Strong revenue generation allows companies to achieve scaling efficiencies, generate continuous shareholder value, and many other clear benefits.
Should You Buy Dick's Sporting Goods Ahead Of Earnings?
Investors are always looking for stocks that are poised to beat at earnings season and Dick’s Sporting Goods, Inc. may be one such company.
These Retail Apparel Stocks Are Standing Out In Terms Of Growth & Value This Earnings Season
Investors looking for stocks with sound value and attractive growth prospects may want to take a look at the retail sector at the moment.
5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024
Things have been looking better for the biotech industry in 2024 after a decent performance in 2023. Here is a look at some biotech stocks that may provide stability to one's portfolio throughout the year.
Pharma Stock Roundup: Novo Nordisk's New Obesity Pill Data, Roche, AstraZeneca's Pipeline Updates
This week, data from Novo Nordisk’s early-stage study on a new weight loss pill called amycretin showed that it could be more effective than Wegovy. Meanwhile, the FDA approved Johnson & Johnson's lung cancer medicine, Rybrevant, for first-line use.
97 to 112 of 10116 Posts
<<< 1 ... 5 6 7 8 9 ... 633 >>>